The findings of a recent study shed light on the role of complement proteins in breast milk and provide a mechanism through which breastfeeding may provide protection from certain bacterial…
Launching a new frontier in IBS management: the 'TrIuMPH' trial sets the stage with EBX-102-02, a pioneer in microbiome-based therapy.
An exclusive interview with Daniel Brownell, Senior Director of Research & Development at AOBiome Therapeutics, whose core technology is ammonia oxidizing bacteria, formulated as a topical suspension of bacteria applied…
The findings of a recent study suggest that antimicrobial-resistance mutations in commensal bacteria can make the microbiota surprisingly resilient to antibiotics.
The findings of a recent study suggest that the gut microbiota contributes to alterations in the levels of metabolites associated with ulcerative colitis.
Antonio Gomes, Principal Scientist at Xbiome, talks about employing deep learning techniques to refine the prediction of natural product structures directly from gene sets.
The findings suggest that microbial metabolites can help to predict who is at increased risk of infection after liver transplant. The results may also help to inform microbiota-targeted therapies.
Socially transmissible microbes may influence human health and play a hidden role in social evolution.
The two companies will work on identifying, analyzing, and understanding respiratory tract microbiome systems.
Elran Haber, CEO at Biomica Ltd, discussed the emerging role of microbiome-based treatments in cancer care.
